PATHWORK DIAGNOSTICS, INC.

PATHWORK DIAGNOSTICS, INC. has 2 AI-enabled medical devices on the FDA list. The first decision was on July 30, 2008 and the most recent on May 17, 2012 (TISSUE OF ORIGIN TEST KIT FFPE). Its most common review panel is Clinical Toxcicology (2 devices).